Biotechnology News

October 16, 2014

RHEINFALL, Switzerland--(BUSINESS WIRE)--Release of an ad hoc announcement pursuant to Art. 53 KR LifeWatch AG (SIX Swiss Exchange: LIFE), a leading provider of medical solutions in remote cardiac monitoring, announces that Cigna Corporation has...

October 16, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today announced the publication of results from two single ascending-dose studies that demonstrated no clinical or...

October 16, 2014

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE:CTLT) (“Catalent”), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it will...

October 16, 2014

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its third-quarter 2014 financial results after the close of the market on Wednesday, October 29, 2014. The company plans to hold a...

October 16, 2014

ARDEN HILLS, Minn.--(BUSINESS WIRE)--IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of body-worn devices, today announced that it will release its 2014 third-quarter results on Wednesday, October 29, 2014...

October 16, 2014

WASHINGTON--(BUSINESS WIRE)--Today, Citizens Against Government Waste (CAGW) released results from a poll conducted from September 30 through October 2, 2014 on the topic of biosimilars, a safe and less expensive alternative for patients who use...

October 16, 2014

MUNDELEIN, Ill.--(BUSINESS WIRE)--With more than two and a half million patients a year suffering from pressure ulcers and other wound and skin care complications, and 60,000 patient deaths directly related to pressure ulcers annually, more needs...

October 16, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Health Canada has issued a Notice of Compliance for Harvoni™ (ledipasvir 90 mg/sofosbuvir 400 mg), the first once-daily single table regimen for the...

October 16, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) will host a live webcast of its fiscal 2015 first-quarter conference call on Wednesday, October 29, 2014, at 3:45 p.m. CT (4:45 p.m. ET). David Martin, President...

October 16, 2014

SAN DIEGO--(BUSINESS WIRE)--Batu Biologics, an immunotherapy company developing an anti-angiogenic cancer vaccine, announced today the signing of a license agreement with the Regents of the University of California, granting exclusive rights to...

October 16, 2014

BERLIN--(BUSINESS WIRE)--OctreoPharm Sciences gets FDA orphan drug designation for management of neuroendocrine tumors

October 16, 2014

TUCSON, Ariz.--(BUSINESS WIRE)--Protein Technologies, a leader in the field of peptide synthesis instrumentation, today announces that researchers at the University of Utah have developed an innovative use of peptide mimics as drug target...

October 16, 2014

WASHINGTON--(BUSINESS WIRE)--Biotechnology companies Solazyme and Amyris have won Presidential Green Chemistry Challenge Awards from EPA for developing cleaner renewable chemicals produced from algae and yeast fermentation.

October 16, 2014

BOSTON & GENEVA--(BUSINESS WIRE)--The PHT eCOA System offers an enhanced version of SmartReports™ with new capabilities that make trial management easier for sponsors, more convenient for sites, and helpful for research participants

October 16, 2014

MINNEAPOLIS--(BUSINESS WIRE)--LifeScience Alley releases Q3 investment data which shows Minnesota life science investment is on pace to surpass a five year high and that state medical device investment is healthy and growing.

October 16, 2014

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will host an Analyst Day on Tuesday, November 18, 2014 from 10:00 a.m. to 11:30 a.m. Eastern time (7:00 a.m. to 8:30 a.m. Pacific time) in New York City. The...

October 16, 2014

SAN DIEGO--(BUSINESS WIRE)--Everyone knows how frustrating the itch of an insect bite can be, but imagine if that itch lasted for months or longer? Chronic itchy skin affects millions of Americans who suffer from eczema, a term for a group of...

October 16, 2014

RAMSEY, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (OTCQB:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious...

October 16, 2014

KEARNEY, Neb.--(BUSINESS WIRE)--SCORR Marketing, a global full-service marketing and communications firm, released survey results that identify current marketing trends in the drug development services industry.

October 16, 2014

BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, Inc., a leader in cancer immunotherapy, today announced that it has entered into its second agreement with Janssen Biotech, Inc., part of the Janssen Pharmaceutical Companies of Johnson &...

October 16, 2014

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris to present three studies on benefits of cryopreserved placental membranes for chronic wounds

October 16, 2014

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific today announced the successful CE-IVD registration of its new Ion PGM Dx System for sale in European countries. The Ion PGM Dx System was developed using the proven Ion Torrent next...

October 16, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today the initiation of a Phase II clinical trial evaluating linaclotide for the treatment of adults suffering from opioid-induced constipation (OIC). Data...

October 16, 2014

OAKLAND, Calif.--(BUSINESS WIRE)--Omicia, Inc., the leading genome interpretation company, today announced the commercial availability of Opal ClinicalTM, the company’s software solution for diagnostic testing organizations. With the cost of next...

October 16, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced encouraging topline data from its Phase 2a exploratory study of duvelisib (IPI-145), its oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and...

October 16, 2014

CHICAGO--(BUSINESS WIRE)--Allegro Ophthalmics, LLC, dedicated to establishing Integrin Peptide Therapy as the next-generation pharmaceutical category for the treatment of vitreo-retinal diseases, today announced that it is enrolling patients in a...

October 16, 2014

TORONTO--(BUSINESS WIRE)--Xagenic, a molecular diagnostics company developing the first lab-free molecular diagnostic platform with a 20 minute time-to-result, today announced the appointment of Timothy I. Still as President and Chief Executive...

October 16, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) today posted strong financial results for the third quarter, which exceeded expectations and provided its fourth quarter and full-year 2014 guidance adjusting for the planned...

October 16, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix and Ariosa announce multi-year supply agreement covering Affymetrix arrays and instruments to be utilized as part of Ariosa’s Harmony Non-Invasive Prenatal Test (NIPT).

October 16, 2014

ZUG, Switzerland & FRANKFURT, Germany--(BUSINESS WIRE)--BIO-Europe® 2014 Program is abundant showcase of life science pharma executives and leading dealmakers from biotech, pharma and finance.

October 16, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--PROVECTUS’ INTRALESIONAL PV-10 CLINICAL DATA TO BE PRESENTED TO THE 2014 INTERNATIONAL CONGRESS OF THE SOCIETY FOR MELANOMA RESEARCH

October 16, 2014

HAMBURG, Germany--(BUSINESS WIRE)--PENTAX Medical will be presenting the latest technologies and programmes designed to ensure excellence in endoscopy on Stand 9, Hall Y at UEGW 2014, Vienna, 18th-22nd October.

October 16, 2014

PARIS--(BUSINESS WIRE)--NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announced today that it has received approval from the French National...

October 16, 2014

YOKOHAMA, Japan--(BUSINESS WIRE)--BioNet Recombinant Pertussis vaccine shows safety and immunogenicity in Phase I/II Clinical Study

October 15, 2014

TAMPA, Fla.--(BUSINESS WIRE)--Laser Spine Institute and Rivenbark Consulting released a study today detailing the income and productivity gains provided by spinal decompression procedures.

October 15, 2014

SALT LAKE CITY--(BUSINESS WIRE)--BioUtah announces the winners of the 2014 Utah Life Science Awards. The Awards will be presented at a special luncheon November 5 at the Grand America Hotel, as part of the Utah Life Science Summit.

October 15, 2014

LEXINGTON & ANDOVER, Mass.--(BUSINESS WIRE)--Ora and SARcode have resolved litigation concerning Ora's intellectual property and the parties have entered into a settlement agreement. Ora has granted SARcode and its affiliates a non-exclusive...

October 15, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Esbriet® (pirfenidone) as a treatment for idiopathic...

October 15, 2014

WASHINGTON--(BUSINESS WIRE)--TherapeuticsMD, Inc. announces positive results from phase 2 and pharmacokinetic studies of TX-004HR; Dr. Pickar will present data at the 25th Annual Meeting of The North American Menopause Society.

October 15, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced that it intends to offer and sell up to $75,000,000 of shares of its common stock in an underwritten public offering. All of the shares of common...

October 15, 2014

BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, Inc., a leader in cancer immunotherapy, today announced that interim data from the Phase 1B clinical trial of its CRS-207 cancer immunotherapy in combination with chemotherapy as a front line...

October 15, 2014

REDMOND, Wash.--(BUSINESS WIRE)--Vesiflo, Inc., today announced that its Direct De Novo Petition for the inFlow™ Urinary Prosthesis has been granted by the U.S. Food and Drug Administration (FDA), allowing the inFlow to be freely marketed in the...

October 15, 2014

BOSTON--(BUSINESS WIRE)--We are pleased to announce that H&Q Healthcare Investors (NYSE: HQH) and H&Q Life Sciences Investors (NYSE: HQL) have changed their names to Tekla Healthcare Investors and Tekla Life Sciences Investors,...

October 15, 2014

TEANECK, N.J.--(BUSINESS WIRE)--Nominations sought for 2014 SAFE-BioPharma "DIGI" Awards

October 15, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--Precision Spine Announces 510(k) Clearance of the VAULT-C Anterior Cervical Interbody Fusion Device

October 15, 2014

CHICAGO--(BUSINESS WIRE)--Vetter Announces Personnel Changes in its Development Service Division to support its customer base. Clinical manufacturing services continue to attract new business.

October 15, 2014

TORONTO--(BUSINESS WIRE)--Xagenic Inc., a molecular diagnostics company developing the first lab-free molecular diagnostic platform with a 20 minute time-to-result, announced today that its project in partnership with the University of Toronto...

October 15, 2014

EXTON, Pa.--(BUSINESS WIRE)--DSM, a global leader in biomedical materials science and regenerative medicine, today announced a collaboration with The Artificial Heart Laboratory at the Foundation of Cardiac Surgery Development (FRK) in Zabrze,...

October 15, 2014

MIDLAND, Mich.--(BUSINESS WIRE)--Washing hands with soap is a proven way to prevent the spread of life-threatening diseases, especially among children. In fact, nearly 2 million children under the age of 5 die each year from infectious diseases....